Tag: FDA Pulmonary-Allergy Drug Advisory Committee (PADAC)

ARS-FDA

ARS Responds to FDA’s Request for Additional Study Before Approving neffy...

FDA Issues Complete Response Letter for neffy® New Drug Application with Request for Additional Study.
neffy®

FDA Delays Approval of neffy™ Intranasal Epinephrine Until September

The expected approval date has been delayed from mid-year.
neffy®

FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray

The first needle-free emergency epinephrine alternative is on the verge of FDA approval.